MX9703918A - Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior. - Google Patents

Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.

Info

Publication number
MX9703918A
MX9703918A MX9703918A MX9703918A MX9703918A MX 9703918 A MX9703918 A MX 9703918A MX 9703918 A MX9703918 A MX 9703918A MX 9703918 A MX9703918 A MX 9703918A MX 9703918 A MX9703918 A MX 9703918A
Authority
MX
Mexico
Prior art keywords
gastrointestinal tract
bacteria
procedure
detect
prepare
Prior art date
Application number
MX9703918A
Other languages
English (en)
Inventor
J Marshall M D Barry
Original Assignee
J Marshall M D Barry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Marshall M D Barry filed Critical J Marshall M D Barry
Priority to MX9703918A priority Critical patent/MX9703918A/es
Priority to SK1622-99A priority patent/SK162299A3/sk
Priority to EP98922526A priority patent/EP1005335A4/en
Priority to JP50001599A priority patent/JP2001526691A/ja
Priority to CN98806744A priority patent/CN1262619A/zh
Priority to PCT/AU1998/000395 priority patent/WO1998053808A1/en
Priority to CA002291685A priority patent/CA2291685C/en
Priority to KR19997011085A priority patent/KR20010013106A/ko
Priority to AU75143/98A priority patent/AU731746B2/en
Priority to US09/424,494 priority patent/US6517809B1/en
Priority to BR9815545-8A priority patent/BR9815545A/pt
Publication of MX9703918A publication Critical patent/MX9703918A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1206—Administration of radioactive gases, aerosols or breath tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Atmospheric Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un procedimiento para obtener un producto de actividad farmacologica encapsulado, para deteccion de desorden gastrointestinal producido por bacteria en el tracto gastrointestinal mediante prueba de aliento, preparado a base de un vehículo denso de azucar, lactosa o fructosa o granos non-pareil o mezclas de los mismos en dispersion o revestidos con un micro curio de isotopo 14C-urea, siendo la mezcla en polvo cubierta con una substancia de gelatina de pronta disolucion en jugos gástricos, con una densidad lo suficiente para que la cápsula obtenida pueda por gravedad depositarse a lo largo de la mucosa del tracto gastrointestinal del estomago de humanos o animales secundarios.
MX9703918A 1997-05-28 1997-05-28 Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior. MX9703918A (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
MX9703918A MX9703918A (es) 1997-05-28 1997-05-28 Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
SK1622-99A SK162299A3 (en) 1997-05-28 1998-05-28 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract
EP98922526A EP1005335A4 (en) 1997-05-28 1998-05-28 PROCESS FOR THE PREPARATION OF A REACTIVE PHARMACEUTICAL PRODUCT FOR THE DETECTION OF GASTROINTESTINAL DISORDER INDUCED BY BACTERIA IN THE SUPERIOR GASTROINTESTINAL PATHWAYS
JP50001599A JP2001526691A (ja) 1997-05-28 1998-05-28 胃腸上管中のバクテリアにより生じた胃腸疾患の検出用の反応性医薬生成物を製造する方法
CN98806744A CN1262619A (zh) 1997-05-28 1998-05-28 制备用于测定由细菌引起的胃肠道疾病的可反应性药品的方法
PCT/AU1998/000395 WO1998053808A1 (en) 1997-05-28 1998-05-28 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract
CA002291685A CA2291685C (en) 1997-05-28 1998-05-28 Pharmaceutical product for the detection of helicobacter pylori-induced gastrointestinal disorder
KR19997011085A KR20010013106A (ko) 1997-05-28 1998-05-28 상부 위장관 내의 세균에 의해 발생하는 위장 질환의검출을 위한 반응성 제약 물질의 제조 방법
AU75143/98A AU731746B2 (en) 1997-05-28 1998-05-28 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract
US09/424,494 US6517809B1 (en) 1997-05-28 1998-05-28 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract
BR9815545-8A BR9815545A (pt) 1997-05-28 1998-05-28 Processo para preparar um produto farmacêutico reativo para a detecção de distúrbio gastrointestinal causado por bactérias no trato gastrointestinal superior e respectivo produto farmacêutico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9703918A MX9703918A (es) 1997-05-28 1997-05-28 Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.

Publications (1)

Publication Number Publication Date
MX9703918A true MX9703918A (es) 1998-11-30

Family

ID=19744975

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703918A MX9703918A (es) 1997-05-28 1997-05-28 Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.

Country Status (11)

Country Link
US (1) US6517809B1 (es)
EP (1) EP1005335A4 (es)
JP (1) JP2001526691A (es)
KR (1) KR20010013106A (es)
CN (1) CN1262619A (es)
AU (1) AU731746B2 (es)
BR (1) BR9815545A (es)
CA (1) CA2291685C (es)
MX (1) MX9703918A (es)
SK (1) SK162299A3 (es)
WO (1) WO1998053808A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201891B1 (en) 2000-05-19 2007-04-10 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
CA2408992C (en) * 2000-05-19 2010-03-23 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
RU2209625C1 (ru) * 2001-12-10 2003-08-10 Масенко Валерий Павлович Радиофармацевтическая композиция для диагностики заболеваний желудочно-кишечного тракта
US6991898B2 (en) * 2003-10-20 2006-01-31 Kimberly-Clark Worldwide, Inc. Diagnostic test device and method of using same
CN102335442B (zh) * 2010-07-21 2013-01-30 深圳市中核海得威生物科技有限公司 尿素[14c]胶囊及其微量分装方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145086A (en) 1960-05-05 1964-08-18 Miles Lab Diagnostic composition
FR1472956A (es) 1964-07-20 1967-06-01
US4153685A (en) 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
IT1053508B (it) 1970-07-06 1981-10-10 Searle & Co Procedimento per prepare composizioni marcate adatte a mettere in evidenza alterazioni della mucosa gastrointestinale prodotto ottenuto e relativo metodo di impiego
US3876502A (en) 1971-10-20 1975-04-08 Mallinckodt Inc Reagent formulations for assaying urea nitrogen in biological specimens and methods of preparing and using same
ZA74385B (en) 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
US3950226A (en) 1974-10-31 1976-04-13 Moon Ki Chang Novel reagent and method for the determination of urea in biological fluids
EP0018825B1 (en) 1979-05-02 1985-02-13 National Research Development Corporation A process for the identification of bacteria and a kit of reagents for use in this process
US4851209A (en) 1982-11-12 1989-07-25 The Regents Of The University Of California Diagnostic procedures using radio labeled sucralfate and derivatives or precursors thereof
US4581221A (en) 1983-08-29 1986-04-08 Medi Nuclear Corporation, Inc. Ulcer detection
US4548805A (en) 1983-12-27 1985-10-22 Sack David A Non-invasive test for gastric acid
US4748113A (en) 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
US5256684A (en) 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
EP0206626B2 (en) 1985-06-13 2002-05-22 Barry James Dr. Marshall Use of Bismuth for the manufacture of a medicament for the treatment of gastrointestinal disorders induced by Campylobacter polyridis
US4830010A (en) * 1986-04-04 1989-05-16 Marshall Barry J Methods for the diagnosis of gastrointestinal disorders
US4923801A (en) 1987-04-13 1990-05-08 The University Of Virginia Alumni Patents Foundation Compositions and methods for the enrichment and isolation of Campylobacter pylori and related organisms from biological specimens and the environment
AU3054789A (en) 1988-03-23 1989-10-16 Julie Claire Dent Detection of campylobacter pylori urease antibodies and reagent therefor
US5304540A (en) 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US4947861A (en) 1989-05-01 1990-08-14 Hamilton Lyle H Noninvasive diagnosis of gastritis and duodenitis
US5258178A (en) 1990-07-30 1993-11-02 Abbott Laboratories Method and product for the treatment of gastric disease
DE4139840B4 (de) 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
US5314804A (en) 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
CA2067603A1 (en) 1992-04-29 1993-10-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva
EP0634644A1 (de) 1993-07-13 1995-01-18 Mic Medical Instrument Corporation Vorrichtung zur Bestimmung des 13CO2/12CO2-Konzentrationsverhältnisses in einer Gasprobe
CN1137732C (zh) 1993-10-28 2004-02-11 巴瑞·马休 胃内幽门螺杆菌的检测
US5439801A (en) 1994-02-14 1995-08-08 Chek-Med Systems, Inc. Test composition for the rapid detection of helicobacter pylori in gastric biopsy tissue
US5542419A (en) 1994-02-28 1996-08-06 Boston University Noninvasive method to detect gastric Helicobacter pylori
US5593851A (en) 1994-04-01 1997-01-14 Chek-Med Systems, Inc. Test kid for the rapid detection of helicobacter pylori in gastric biopsy tissue
JPH07289289A (ja) 1994-04-27 1995-11-07 Gastec:Kk ヘリコバクター・ピロリの簡易検査法及び検査器具
SE504902C2 (sv) * 1994-11-02 1997-05-26 Diabact Ab Beredning för påvisande av Helicobacter pylori i magsäcken
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
WO1997038110A2 (en) 1996-04-05 1997-10-16 Kieta Holding S.A. Compositions and methods relating to drug discovery and detection and treatment of gastrointestinal diseases
SE9601659D0 (sv) * 1996-04-30 1996-04-30 Diabact Ab Diagnostisk läkemedelsberedning
US5738110A (en) 1996-05-29 1998-04-14 Beal; Charles B. Device for the diagnosis of certain gastrointestinal pathogens
US5848975A (en) 1996-07-01 1998-12-15 St. Vincent's Medical Center Of Richmond Breath test for helicobacter pylori
EA000913B1 (ru) 1996-08-13 2000-06-26 Кийова Хакко Когио Ко., Лтд. Таблетка меченной изотопом мочевины
US5702911A (en) 1996-08-15 1997-12-30 Chek-Med Systems, Inc. Diagnostic test composition
ES2120903B1 (es) 1996-11-12 1999-05-16 Isomed S L Metodo y kit para la deteccion de helicobacter pylori.
AUPO425896A0 (en) * 1996-12-18 1997-01-23 University Of Wollongong, The Method and apparatus for measuring gas concentrations and isotope ratios in gases
EP1019061A4 (en) 1997-01-29 2006-08-23 Univ Johns Hopkins UREASE RELEASE DELIVERY SYSTEMS FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
US6067989A (en) 1997-02-26 2000-05-30 Oridion Medical, Ltd. Breath test for the diagnosis of Helicobacter pylori infection in the gastrointestinal tract
US5989840A (en) 1997-05-29 1999-11-23 Americare International Diagnostics, Inc. Estimation of active infection by heliobacter pylori
WO1999061892A1 (en) 1998-03-06 1999-12-02 Angelo Joseph P D Estimation of active infection by helicobacter pylori
KR100247941B1 (ko) 1998-04-03 2000-04-01 하영칠 헬리코박터 피롤리의 검출용 조성물, 검출용 키트 및 검출방법
US6165736A (en) 1998-07-28 2000-12-26 The Nemours Foundation Method of detecting bacterial infection

Also Published As

Publication number Publication date
EP1005335A1 (en) 2000-06-07
CA2291685A1 (en) 1998-12-03
SK162299A3 (en) 2000-07-11
CN1262619A (zh) 2000-08-09
WO1998053808A1 (en) 1998-12-03
AU7514398A (en) 1998-12-30
JP2001526691A (ja) 2001-12-18
CA2291685C (en) 2008-07-29
EP1005335A4 (en) 2000-09-20
AU731746B2 (en) 2001-04-05
BR9815545A (pt) 2001-11-06
KR20010013106A (ko) 2001-02-26
US6517809B1 (en) 2003-02-11

Similar Documents

Publication Publication Date Title
RU1797470C (ru) Состав дл капсулировани биологически активного вещества
DE69729950D1 (de) System zur verzögerten freisetzung säurelabiler substanzen
HUP0000943A2 (hu) Expandálható gasztro-retentív terápiás rendszer szabályozott hatóanyag felszabadítással a gyomor-béltraktusban
HU905812D0 (en) Process for the preparation of two-layered granulates containing dinatrium-3-amino-1-hydroxy-propane-1, 1-diphosphonate
UA41995C2 (uk) Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти )
EP0222411A3 (en) Method of preparing sustained-release pharmaceutical preparation
HK1047226A1 (zh) 流体力学平衡口服药输送系统
MY102675A (en) Pharmaceutical formulations of acid labile substances for oral use.
CA2181502A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
SG164281A1 (en) Controlled release preparation
IE871584L (en) Sustained release capsule.
US20190365645A1 (en) Drug delivery articles for gram-level dosing
MX9703918A (es) Procedimiento para preparar un producto farmaceutico reactivo para deteccion de desorden gastrointestinal causado por bacteria en el tracto gastrointestinal superior.
ES2130056B1 (es) Un nuevo preparado farmaceutico para mejorar la biodisponibilidad oral de drogas de dificil absorcion.
KR102182762B1 (ko) 인간 유기체에서 자성체들을 검출하기 위한 개인맞춤화 시스템
CA2121038A1 (en) Oral preparation for release in lower digestive tracts
MY107811A (en) Polyamine drug-resin complexes
AU2795697A (en) A preparation for the detection of urease activity in the gastric tract
EP0305968A3 (en) Compositions against protozoal diseases
AU4663999A (en) Diagnostic method and diagnostic means used in carrying out said method
Tsuchiya et al. Treatment of unresectable hepatocellular carcinoma by arterial infusion of mitomycin C microcapsules (MMCmc)
US20070077294A1 (en) Capsules comprising topiramate
Maugh Sleep-Promoting Factor Isolated: Glycopeptide from human urine causes a 50 percent increase in deep sleep in animals
Kunes et al. Imaging and evaluating method as part of endoscopical diagnostic approaches
TH57760A3 (th) การลำเลียงแบบเอนเทอริกและโคโลนิก โดยใช้แคปซูลชนิด hpmc

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees